The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow et al.
Neurology 2009;72:S1-S136.
ABSTRACT
| FULL TEXT
Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A2A receptor knockout mice with microarray profiling
Yu et al.
Physiol. Genomics 2009;37:199-210.
ABSTRACT
| FULL TEXT
Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (ARIC) Study
Chen et al.
Am J Epidemiol 2009;169:1064-1069.
ABSTRACT
| FULL TEXT
Caffeine Stimulates Cytochrome Oxidase Expression and Activity in the Striatum in a Sexually Dimorphic Manner
Jones et al.
Mol. Pharmacol. 2008;74:673-684.
ABSTRACT
| FULL TEXT
Differential Effects of Black versus Green Tea on Risk of Parkinson's Disease in the Singapore Chinese Health Study
Tan et al.
Am J Epidemiol 2008;167:553-560.
ABSTRACT
| FULL TEXT
Adenosine A2A Receptors in Bone Marrow-Derived Cells But Not in Forebrain Neurons Are Important Contributors to 3-Nitropropionic Acid-Induced Striatal Damage as Revealed by Cell-Type-Selective Inactivation.
Huang et al.
J. Neurosci. 2006;26:11371-11378.
ABSTRACT
| FULL TEXT
A Tail of Two Signals: The C Terminus of the A2A-Adenosine Receptor Recruits Alternative Signaling Pathways
Gsandtner and Freissmuth
Mol. Pharmacol. 2006;70:447-449.
ABSTRACT
| FULL TEXT
Estrogen Prevents Neuroprotection by Caffeine in the Mouse 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease
Xu et al.
J. Neurosci. 2006;26:535-541.
ABSTRACT
| FULL TEXT
Excessive daytime sleepiness and subsequent development of Parkinson disease
Abbott et al.
Neurology 2005;65:1442-1446.
ABSTRACT
| FULL TEXT
Evidence-based toxicology: a comprehensive framework for causation
Guzelian et al.
Hum Exp Toxicol 2005;24:161-201.
ABSTRACT
Consumption of milk and calcium in midlife and the future risk of Parkinson disease
Park et al.
Neurology 2005;64:1047-1051.
ABSTRACT
| FULL TEXT
Parkinson's disease: the first common neurological disease due to auto-intoxication?
Williams et al.
QJM 2005;98:215-226.
ABSTRACT
| FULL TEXT
Coffee Consumption, Gender, and Parkinson's Disease Mortality in the Cancer Prevention Study II Cohort: The Modifying Effects of Estrogen
Ascherio et al.
Am J Epidemiol 2004;160:977-984.
ABSTRACT
| FULL TEXT
Caffeine as a Neuroprotective Adenosine Receptor Antagonist
Dall'Igna et al.
The Annals of Pharmacotherapy 2004;38:717-718.
FULL TEXT
Coffee Consumption and Risk of Type 2 Diabetes Mellitus Among Middle-aged Finnish Men and Women
Tuomilehto et al.
JAMA 2004;291:1213-1219.
ABSTRACT
| FULL TEXT
Receptor heteromerization in adenosine A2A receptor signaling: Relevance for striatal function and Parkinson's disease
Fuxe et al.
Neurology 2003;61:S19-23.
ABSTRACT
| FULL TEXT
Caffeinated clues from epidemiology of Parkinson's disease
Ascherio and Chen
Neurology 2003;61:S51-54.
FULL TEXT
Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease
Chen et al.
Arch Neurol 2003;60:1059-1064.
ABSTRACT
| FULL TEXT
Parkinsonian signs in older people: Prevalence and associations with smoking and coffee
Louis et al.
Neurology 2003;61:24-28.
ABSTRACT
| FULL TEXT
Update on Parkinson Disease
Siderowf and Stern
ANN INTERN MED 2003;138:651-658.
ABSTRACT
| FULL TEXT
Caffeine, postmenopausal estrogen, and risk of Parkinson's disease
Ascherio et al.
Neurology 2003;60:790-795.
ABSTRACT
| FULL TEXT
Survival Study of Parkinson Disease in Olmsted County, Minnesota
Elbaz et al.
Arch Neurol 2003;60:91-96.
ABSTRACT
| FULL TEXT
Smoking and PD in twins
Allam et al.
Neurology 2002;59:1821-1822.
FULL TEXT
Coffee Consumption and Cognitive Function among Older Adults
Johnson-Kozlow et al.
Am J Epidemiol 2002;156:842-850.
ABSTRACT
| FULL TEXT
Plantation Work and Risk of Parkinson Disease in a Population-Based Longitudinal Study
Petrovitch et al.
Arch Neurol 2002;59:1787-1792.
ABSTRACT
| FULL TEXT
Midlife adiposity and the future risk of Parkinson's disease
Abbott et al.
Neurology 2002;59:1051-1057.
ABSTRACT
| FULL TEXT
8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism
Chen et al.
J. Biol. Chem. 2002;277:36040-36044.
ABSTRACT
| FULL TEXT
Caffeinated clues and the promise of adenosine A2A antagonists in PD
Schwarzschild et al.
Neurology 2002;58:1154-1160.
ABSTRACT
| FULL TEXT
Parkinson's Disease Risks Associated with Cigarette Smoking, Alcohol Consumption, and Caffeine Intake
Checkoway et al.
Am J Epidemiol 2002;155:732-738.
ABSTRACT
| FULL TEXT
Smoking and Parkinson's disease in twins
Tanner et al.
Neurology 2002;58:581-588.
ABSTRACT
| FULL TEXT
Frequency of bowel movements and the future risk of Parkinson's disease
Abbott et al.
Neurology 2001;57:456-462.
ABSTRACT
| FULL TEXT
An algorithm (decision tree) for the management of Parkinson's disease (2001):: Treatment
Olanow et al.
Neurology 2001;56:S1-S88.
FULL TEXT
Smoking, alcohol, and coffee consumption preceding Parkinson's disease
Deleu et al.
Neurology 2001;56:984-985.
FULL TEXT
Molecular Mechanisms Controlling the Rate and Specificity of Catechol O-Methylation by Human Soluble Catechol O-Methyltransferase
Lautala et al.
Mol. Pharmacol. 2001;59:393-402.
ABSTRACT
| FULL TEXT
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: A case-control study
Benedetti et al.
Neurology 2000;55:1350-1358.
ABSTRACT
| FULL TEXT
Relationship Between Caffeine Intake and Parkinson Disease
Honig et al.
JAMA 2000;284:1378-1379.
FULL TEXT
Coffee, Tea, and Risk for PD
JWatch Neurology 2000;2000:5-5.
FULL TEXT
General Medicine: Caffeine Associated with Reduced Parkinson's Disease Risk
JWatch Psychiatry 2000;2000:12-12.
FULL TEXT
Caffeine Associated with Reduced Parkinson's Disease Risk
JWatch General 2000;2000:6-6.
FULL TEXT
Neuroprotection by Caffeine and A2A Adenosine Receptor Inactivation in a Model of Parkinson's Disease
Chen et al.
J. Neurosci. 2001;21:RC143-RC143.
ABSTRACT
| FULL TEXT